The Effectiveness of Atezolizumab in Metastatic Large Cell Neuroendocrine Carcinoma of the Lungs: Insights from the LANCE Pilot Study.
Georgios EvangelouIoannis P TrontzasIoannis GkiozosIoannis VamvakarisChristina ParaskevaMaria GrammoustianouGeorgia GomatouIoannis TsamisIoannis A VathiotisMaximillian AnagnostakisVasiliki KoliarakiKostas SyrigosPublished in: Biomedicines (2024)
This pilot study suggests that the addition of atezolizumab to standard platinum-based chemotherapy may provide a substantial survival benefit compared with chemotherapy alone in the first-line treatment of metastatic LCNEC.